Autism: A form of lead and mercury toxicity

Environmental Toxicology and Pharmacology

Volumn 38, Issue 3, 2014, Pages 1016-1024

  Yassa, Heba A ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Autism; Autistic symptoms; Chelating agents; Heavy metals

Indexed keywords

LEAD; MERCURY; SUCCIMER; CHELATING AGENT; POLLUTANT;

ARTICLE; ATOMIC ABSORPTION; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; FEMALE; HAIR ANALYSIS; HEAVY METAL BLOOD LEVEL; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MALE; MASS SPECTROMETRY; MERCURIALISM; MERCURY BLOOD LEVEL; METAL METABOLISM; QUESTIONNAIRE; RISK FACTOR; URINARY EXCRETION; AUTISTIC DISORDER; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; POLLUTANT; PRESCHOOL CHILD; TREATMENT OUTCOME;

AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LEAD; MALE; MERCURY; QUESTIONNAIRES; RISK FACTORS; SUCCIMER; TREATMENT OUTCOME;

EID: 84911109304     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.10.005     Document Type: Article

References (41)

1. Adams J., Bara M., Geis E., Mitchell J., Ingram J., Hensley A., Zappia I., Newmark S., Gehn E., Rubin R., Mitchell K., Bradstreet J., El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A - medical results. BMC Clin. Pharmacol. 2009, 9:16. 10.1186/1472-6904-9-16.
2. Adams J., Bara M., Geis E., Mitchell J., Ingram J., Hensley A., Zappia I., Newmark S., Gehn E., Rubin R., Mitchell K., Bradstreet J., El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin. Pharmacol. 2009, 9:17. 10.1186/1472-6904-9-17.
3. Adams J., Audhya T., McDonough-Means S., Rubin R., Quig D., Geis E., Gehn E., Loresto M., Mitchell J., Atwood S., Barnhouse S., Lee W. Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biol. Trace Elem. Res. 2013, 151(2):171-180.
4. Al-Salehi S.M., Ghaziuddin M. G6PD deficiency in autism: a case-series from Saudi Arabia. Eur. Child Adolesc. Psychiatry 2009, 18(4):227-230.
5. Autism Research Institute Treatment Options for Mercury/Metal Toxicity in Autism and Related Developmental Disabilities: Consensus Position Paper 2005, www.Autism Research Institute.com.
6. Bernard S., Enayati A., Redwood L., Roger H., Binstock T. Autism: a novel form of mercury poisoning. Med. Hypotheses 2001, 56:462-471.
7. Blaurock-Busch E., Amin O., Dessoki H., Rabah T. Toxic metals and essential elements in hair and severity of symptoms among children with autism. J. Clin. Med. 2012, 7(1):38-48.
8. Blaurock-Busch E., Amin O., Rabah T. Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder. J. Clin. Med. 2011, 6(4):247-257.
9. Blumberg S., Bramlett M., Kogan M., Schieve L., Jones J., Lu M. Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011-2012 2013, vol. 65:1-12. National Health Statistics Reports.
10. Boseila S., Gabr A., Hakim I. Blood lead levels in egyptian children: influence of social and environmental factors. Am. J. Public Health 2004, 94(1):47-50.
11. Boyle C.A., Boulet S., Schieve L.A., Cohen R.A., Blumberg S.J., Yeargin-Allsopp M., et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011, 127(6):1034-1042.
12. Carpenter L. DSM-5 Autism Spectrum Disorder, Guidelines and Criteria 2013, https://depts.washington. edu/dbpeds/Screening%20 Tools/DSM-5(ASD.Guidelines)Feb2013.pdf.
13. CDC - Center for Disease Control Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008 2012, vol. 61(SS03):1-19. MMWR.
14. CDC - Center for Disease Control Lead Poisoning, Words to Know From A to Z 2013, www.cdc.gov/nceh/lead.
15. Demicheli V., Rivetti A., Debalini M.G., Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. CDS Rev. 2012, 15(2):CD004407.
16. DeStefano F., Chen R.T. Autism and measles-mumps-rubella vaccination: controversy laid to rest?. CNS Drugs 2001, 15(11):831-837.
17. El-baz F., Elhossiny R., Elsayed A., Gaber G. Hair mercury measurement in Egyptian autistic children. Egypt. J. Med. Human Genet. 2010, 11:135-141.
18. Halsey N.A., Hyman S.L. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois. Pediatrics 2001, 107(5):E84.
19. Hartzell S., Seneff S. Impaired sulfate metabolism and epigenetics: is there a link in autism?. Entropy 2012, 14:1953-1977.
20. Hussein H., Taha G., Almanasef A. Characteristics of autism spectrum disorders in a sample of Egyptian and Saudi patients: transcultural cross sectional study. Child Adolesc. Psychiatry Ment. Health 2011, 5(34):1-12.
21. James S., Cutler P., Melny k.S., Jernigan S., Janak L., Gaylor D., Neubrander J. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80:1611-1617.
22. Kapp M. Ethical and legal issues in research involving human subjects: do you want a piece of me?. J. Clin. Pathol. 2006, 59(4):335-339.
23. Keller F., Persico A.M. The neurobiological context of autism. Mol. Neurobiol. 2003, 28(1):1-22.
24. Larsson H., Eaton W., Madsen K., Vestergaard M., Olesen A., Agerbo E., Schendel D., Thorsen P., Mortensen P. Risk factors for autism: perinatal factors. parental psychiatric history, and socioeconomic status. Am. J. Epidemiol. 2005, 161(10):916-925.
25. Levy A., Perry A. Outcomes in adolescents and adults with autism: a review of the literature. Res. Autism Spectr. Disord. 2011, 5:1271-1282.
26. London E. The environment as an etiologic factor in autism: a new direction for research. Environ. Health Perspect. 2000, 108:401-404.
27. Lyall K., Schmidt R.J., Hertz-Picciotto I. Maternal life style and environmental risk factors for autism spectrum disorders. Int. J. Epidemiol. 2014, 43(2):443-464.
28. Mutter J., Naumann J., Schneider R., Walach H., Haley B. Mercury and autism: accelerating evidence?. Neuroendocrinol. Lett. 2005, 26(5):439-446.
29. NIOSH Manual of Analytical Methods Elements in Blood or Tissue. Form 8005 1994.
30. Obrenovich M., Shamberger R., Lonsdale D. Altered heavy metals and transketolase found in autistic spectrum disorder. Biol. Trace Elem. Res. 2011, 144(1-3):475-486.
31. Parner E., Cohen S., Lauritsen M., Jorgensen M., Schieve L., Allsopp M., Obel C. Parental age and autism spectrum disorders. Ann. Epidemiol. 2012, 22(3):143-150.
32. Priya L., Geetha A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol. Trace Elem. Res. 2011, 142(2):148-158.
33. Razagui I., Haswell S. The Determination of mercury and selenium in maternal and neonatal scalp hair by inductively coupled plasma-mass spectrometry. J. Anal. Toxicol. 1997, 21:149-153.
34. Rossignol D.A., Genuis S.J., Frye R.E. Environmental toxicants and autism spectrum disorders: a systematic review. Transl. Psychiatry 2014, 11:4-360.
35. Sung Y.J., Dawson G., Munson J., Estes A., Schellenberg G.D., Wijsman E.M. Genetic investigation of quantitative traits related to autism: use of multivariate polygenic models with ascertainment adjustment. Am. J. Hum. Genet. 2005, 76(1):68-81.
36. Taylor B., Miller E., Farrington C.P., Petropoulos M.C., Favot-Mayaud I., Li J., Waight P.A. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999, 353(9169):2026-2069.
37. Tsuchiya K., Matsumoto M., Miyachi T., Tsujii M., Nakamura K., Takagai S., Kawai M., Yagi A., Iwaki K., Suda S., Sugihara G., Iwata Y., Matsuzaki H., Sekine Y., Suzuki K., Sugiyama T., Mori N., Takei N. Paternal age at birth and high-functioning autistic-spectrum disorder in offspring. Br. J. Psychiatry 2008, 193:316-321.
38. Tyler F., Smith L.K., McGrother C.W., Taub N.A. The impact of physical, intellectual and social impairments on survival in adults with intellectual disability: a population-based register study. J. Appl. Res. Intellect. Disabil. 2007, 20:360-367.
39. US Census Bureau, International Database, 2004. RightDiagnosis.com (accessed 03.2014).
40. Walsh W., Usman A., Tarpey J. Disordered metal metabolism in a large autism population. American Psychiatric Association Annual Meeting 2001, http://www.safeminds.org/research/library/20010501.pdf.
41. Windham G.C., Zhang L., Gunier R., Croen L.A., Grether J.K. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay area. Environ. Health Perspect. 2006, 114(9):1438-1444.